Salomon & Ludwin’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.1K Hold
486
– – ﹤0.01% 979
2026
Q2
$17.5K Buy
486
+316
+186% +$10K ﹤0.01% 1250
2026
Q1
$4.72K Sell
170
-70
-29% -$2.3K ﹤0.01% 1777
2025
Q4
$8.82K Buy
240
+152
+173% +$5K ﹤0.01% 1514
2025
Q3
$2.4K Buy
+88
New +$3.03K ﹤0.01% 1950

Other funds holding HRMY

Salomon & Ludwin's HRMY Position: Q3 2026 in Review

Salomon & Ludwin held its Harmony Biosciences (HRMY) position steady in Q3 2026 at 486 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #979.

Salomon & Ludwin first reported a position in HRMY in Q3 2025 and has held it in 5 quarters since. 353 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Salomon & Ludwin held 486 shares of Harmony Biosciences worth $19.1K as of Q3 2026.
  • Salomon & Ludwin left its Harmony Biosciences share count unchanged in Q3 2026.
  • Harmony Biosciences made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #979 holding.
  • Salomon & Ludwin first reported a position in Harmony Biosciences in Q3 2025 and has held it in 5 quarters since.
  • 353 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.